System Formulary Update
Magnesium Products
Situation
The magnesium products class review and formulary standardization was approved at the October 2019 System Pharmacy and Therapeutics Committee meeting.
Background
The following medications were reviewed: magnesium carbonate oral solution, magnesium oxide tablet, magnesium sulfate injection
Assessment/Recommendation
Changes effective: Tuesday, June 29, 2021
System P&T voted to include the following products on the UNC Health Care System Drug Formulary:
As a result, the following products will be removed from the inpatient drug formulary:
Non-formulary orders will be converted according to the following therapeutic interchange:
Non-Formulary Order |
Formulary Equivalent Order |
Magnesium gluconate tablet 500 mg (27 mg elemental magnesium) once daily 500 mg (27 mg elemental magnesium) twice daily |
Magnesium oxide tablet 400 mg (240 mg elemental magnesium) once daily 400 mg (240 mg elemental magnesium) twice daily |
Magnesium chloride tablet, DR 535 mg (64 mg elemental magnesium) once daily 535 mg (64 mg elemental magnesium) twice daily |
Magnesium oxide tablet 200 mg (120 mg elemental magnesium) once daily 200 mg (120 mg elemental magnesium) twice daily |
Magnesium chloride tablet, DR 535 mg (64 mg elemental magnesium) once daily 535 mg (64 mg elemental magnesium) twice daily |
Magnesium oxide tablet 200 mg (120 mg elemental magnesium) once daily 200 mg (120 mg elemental magnesium) twice daily |